Association of the European Self-Care Industry

AESGP

AESGP represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices in Europe.

Links

Website Transparency Register Profile

ID: 99565011637-64

Lobbying Activity

Meeting with Olivér Várhelyi (Commissioner)

3 Nov 2025 · Challenges face by the self-care sector

Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices as regards simplification and burden reduction

6 Oct 2025

Meeting with Olga Solomon (Head of Unit Health and Food Safety) and

3 Oct 2025 · The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition.

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

4 Sept 2025 · Revision of the EU Pharmaceutical Directive

Meeting with Flora Giorgio (Head of Unit Health and Food Safety)

15 Jul 2025 · AESGP presented the association, and the portfolio of products covered.

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

6 Jul 2025

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Meeting with Rainer Becker (Director Health and Food Safety)

25 Mar 2025 · Discussion on selected provisions of the pharma reform, Exchange of views on the Urban Wastewater Treatment Directive

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form

21 Mar 2025

Meeting with Sander Smit (Member of the European Parliament) and European Federation of Pharmaceutical Industries and Associations

21 Mar 2025 · ENVI-general

Response to Targeted evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostics

20 Mar 2025

Meeting with Ariane Vander Stappen (Head of Unit Health and Food Safety) and

4 Mar 2025 · Discussion on the ongoing harmonisation of maximum permitted limits for vitamins and minerals in food

Response to European Water Resilience Strategy

3 Mar 2025

Response to Critical Medicines Act

27 Feb 2025

Meeting with Anne Simon (Head of Unit Health Emergency Preparedness and Response Authority)

24 Feb 2025 · Discuss how the AESGP can support and align with HERA mission Exchange of views on stockpiling, the catalogue, and program to follow regarding medical devices in terms of similar activities like Critical Medicines Alliance

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament)

29 Jan 2025 · Introductory Meeting

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... amending Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and of the Council and Directive 2001/83/EC of the European Parliament and of the Council

15 Jan 2025

Meeting with Tomislav Sokol (Member of the European Parliament) and AstraZeneca PLC

14 Nov 2024 · Health policy

Meeting with Margarita De La Pisa Carrión (Member of the European Parliament)

23 Sept 2024 · Self-care products

Meeting with Tilly Metz (Member of the European Parliament)

18 Sept 2024 · pharmaceutical policy

Meeting with Lukas Sieper (Member of the European Parliament)

17 Jul 2024 · Introductory meeting at networking event

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council as regards the format of the labels for certain products and equipment containing fluorinated greenhouse gases and repealing Commission Implementing Regulation (EU) 2015/2068

4 Jun 2024

Response to Evaluation of the European Food Safety Authority (EFSA) 2017-2024

8 Apr 2024

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 2011/65/EU of the European Parliament and of the Council as regards the re-attribution of scientific and technical tasks to the European Chemicals Agency

3 Apr 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EC) No 178/2002, (EC) No 401/2009, (EU) 2017/745 and (EU) 2019/1021 of the European Parliament and of the Council as regards the re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals

3 Apr 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing a common data platform on chemicals, laying down rules to ensure that the data contained in it are findable, accessible, interoperable and reusable and establishing a monitoring and outlook framework for chemicals

3 Apr 2024

Response to COMMISSION REGULATION (EU) …/… on the use of bisphenol A (BPA) and other bisphenols and their derivatives with harmonised classification for specific hazardous properties in certain materials and articles intended to come into contact with food, amending Regulation (EU) No 10/2011, amending Regulation (EC) No 1895/2005 and repealing Regulation (EU) 2018/213

8 Mar 2024

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

29 Feb 2024

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

15 Feb 2024 · discussion on the revision of Pharmaceutical Legislation

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

26 Jan 2024 · Pharmaceutical legislation

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods as regards the definition of ‘engineered nanomaterials’

12 Jan 2024

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

26 Sept 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on substantiation and communication of explicit environmental claims (Green Claims Directive)

20 Jul 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

19 Jul 2023

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

13 Jul 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC

24 Apr 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

30 Mar 2023

Meeting with Deirdre Clune (Member of the European Parliament, Shadow rapporteur) and

29 Mar 2023 · Stakeholder Consultation on Urban Waste Water Treatment Directive

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL concerning urban wastewater treatment (recast)

14 Mar 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 2000/60/EC establishing a framework for Community action in the field of water policy, Directive 2006/118/EC on the protection of groundwater against pollution and deterioration and Directive 2008/105/EC on environmental quality standards in the field of water policy

14 Mar 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council

7 Feb 2023

Response to Fitness check of how the Polluter Pays Principle is applied to the environment

9 Dec 2022

Response to Proposal for a Regulation of the European Parliament and the Council on the European Chemicals Agency (ECHA Basic Regulation)

10 Oct 2022

Response to Proposal for a Regulation of the European Parliament and of the Council on streamlining chemicals-related data flows, increasing data interoperability, dissemination and re-use across legislation, the notification of commissioned studies, the use of academic studies and the establishment of a mechanism for data generation for the purpose of chemical safety assessments in the context of the European chemicals regulatory framework

16 Aug 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

28 Jul 2022

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

24 May 2022 · Exchange of views on the upcoming reform of the pharmaceutical legislation

Response to Proposal for a Regulation of the European Parliament and of the Council on (re-)attribution of scientific and technical work on chemicals to the EU agencies

12 Apr 2022

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directives 2001/20/EC and 2001/83/EC as regards derogations from certain obligations concerning certain medicinal products for human use made available in the United Kingdom in respect of Northern Ireland, as well as in Cyprus, Ireland and Malta

18 Mar 2022

Meeting with Sandra Gallina (Director-General Health and Food Safety)

9 Sept 2021 · Presentation of the work of AESGP and perspectives from the self care industry on the pharmaceutical strategy.

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

6 Aug 2021

Response to COMMISSION REGULATION (EU) …/… amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast rice

17 Jun 2021

Meeting with Stella Kyriakides (Commissioner) and

7 Jun 2021 · VTC meeting - Access to Medicines

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Meeting with Margaritis Schinas (Vice-President) and

8 Apr 2021 · Health Union

Response to Proposal for a Regulation of the European Parliament and of the Council establishing a European Health Emergency Response Authority (HERA)

24 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

3 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

2 Feb 2021

Meeting with Stella Kyriakides (Commissioner) and

6 Nov 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Stella Kyriakides (Commissioner) and

30 Sept 2020 · Call with pharmaceutical and medical device supply Chain on COVID-19

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020

Meeting with Stella Kyriakides (Commissioner) and

29 Jun 2020 · Call with pharmaceutical and medical device industry associations on COVID-19

Meeting with Stella Kyriakides (Commissioner) and

29 Jun 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Stella Kyriakides (Commissioner) and

29 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

15 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

8 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

29 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

Response to COMMISSION REGULATION (EU) …/… amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards botanical species containing hydroxyanthracene derivatives

23 Apr 2020

Meeting with Stella Kyriakides (Commissioner) and

23 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

Meeting with Stella Kyriakides (Commissioner) and

17 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

3 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

3 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

27 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

27 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

20 Mar 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

Response to Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social Committee and the Committee of the Regions on the Farm to Fork Strategy for a Sustainable Food System

16 Mar 2020

Meeting with Stella Kyriakides (Commissioner) and

13 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Anne Bucher (Director-General Health and Food Safety)

9 Sept 2019 · introduction of AESGPand activities, namely in the area of pharmaceuticals, food supplements; public health issues such as AMR; sustainability of health systems

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the transparency and sustainability of the EU risk assessment in the food chain amending Regulation (EC) No 178/2002 [on general food law], Directive 2001/18/EC [on the deliberate release into the environment of GMOs], Regulation (EC) No 1829/2003 [on GM food and feed], Regulation (EC) No 1831/2003 [on feed additives], Regulation (EC) No 2065/2003 [on smoke flavourings], Regulation (EC) No 1935/2004 [on food contact materials], Regulation (EC) No 1331/2008 [on the common authorisation procedure for food additives, food enzymes and food flavourings], Regulation (EC) No 1107/2009 [on plant protection products] and Regulation (EU) No 2015/2283 [on novel foods]

25 Jun 2018

Meeting with Vytenis Andriukaitis (Commissioner) and

15 Jun 2018 · HTA

Response to Commission Proposal for a Regulation on transparency and sustainability of the EU food and feed safety risk assessment model amending Regulation (EC) No 178/2002 Regulation (EC) No 178/2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety; and Directive 2001/18/EC on the deliberate release into the environment of GMOs, Regulation (EC) No 1829/2003 on GM food and feed, Regulation (EC) No 1831/2003 on feed additives, Regulation (EC) No 2065/2003 on smoke flavourings, Regulation (EC) No 1935/2004 on food contact materials, Regulation (EC) No 1331/2008 on the common authorisation procedure for food additives, food enzymes and food flavourings, Regulation (EC) No 1107/2009 on plant protection products and Regulation (EU) No 2015/2283 on novel foods.

17 Jan 2018

Response to Fitness Check (evaluation) of the Water Framework Directive (2000/60/EC) and the Floods Directive (2007/60/EC)

17 Nov 2017

Response to COMMISSION IMPLEMENTING DECISION (EU) …/… on the group of products whose principal intended action, depending on proanthocyanidins (PAC) present in cranberry (Vaccinium Macrocarpon), is to prevent or treat cystitis

28 Mar 2017

Meeting with Markus Schulte (Digital Economy)

24 Nov 2016 · digitisation in the medical sector